Clinical Research Directory

Inclusion Criteria: * Age range between 30 to 50 years. * Male and female patients will participate in the study. * All patients have chronic rhinosinusitis, who are experiencing 12 weeks or longer of 2 or more of the following signs and symptoms: mucopurulent drainage (anterior, posterior, or both) nasal obstruction (congestion) facial pain-pressure-fullness, or decreased sense of smell • All patients enrolled in the study will have their informed consent. Exclusion Criteria: * Patients with metal implants (pacemakers, dental implants, or any other implants). * Patients with cancer, pregnancy or impaired vascular circulation. * Patients who suffer from mental or psychological disorders. * Patients with any systemic diseases that may interfere with the objectives of the study. * Patients with long-term use of corticosteroids or immunosuppressive agents. * Congenital defects on face and nose. * Fracture of nose or face. * Patients who are contraindicated for corticosteroids use in patient who will receive dexamethasone phonophoresis. * Allergic patients. * Pervious nasal surgery. * Patients with nasal septum deviation. * patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks or any medication that may interfere with the objectives of the study.